<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35100092</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1555-8576</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer biology &amp; therapy</Title>
          <ISOAbbreviation>Cancer Biol Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p/FOXO1 axis.</ArticleTitle>
        <Pagination>
          <StartPage>76</StartPage>
          <EndPage>88</EndPage>
          <MedlinePgn>76-88</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/15384047.2021.2017222</ELocationID>
        <Abstract>
          <AbstractText>Colorectal adenocarcinoma (COAD) is a prevalent malignant tumor. Cancer-associated fibroblasts (CAFs)-derived extracellular vesicles (EVs) (CAFs-EVs) are implicated in COAD treatment. This study explored the mechanism of CAFs-EVs in COAD. CAFs and normal fibroblast (NFs) were isolated from COAD tissues and adjacent normal tissues. Vimentin, α-SMA, and FAP expressions were detected. EVs were isolated from CAFs and identified. SW480 and HCT116 cells were co-incubated with EVs. The EV uptake and COAD cell malignant behaviors were assessed. EV-treated SW480 and HCT116 cells were co-cultured with human umbilical vein endothelial cells (HUVECs). Extensive analyses were conducted to examine HUVEC proliferation, migration, and angiogenesis, and miR-135b-5p expression in COAD cells, and SW480 and HCT116 cells. CAFs were transfected with the miR-135b-5p inhibitor. miR-135b-5p downstream targets were predicted. FOXO1 expression in the co-culture system was determined and then overexpressed to evaluate its role in HUVECs mediated by COAD cells. COAD mouse model was established by transplanting SW480 cells into nude mice and injecting with EVs. Tumor growth rate, volume, and weight were examined. Ki67, VEGF, CD34, FOXO1 expressions, and VEGF content were detected. CAFs-EVs promoted COAD cell malignant behaviors and COAD cells-mediated HUVEC proliferation, migration, and angiogenesis. CAFs-EVs delivered miR-135b-5p into COAD cells. miR-135b-5p targeted FOXO1. Inhibition of miR-135b-5p in EVs or overexpression of FOXO1 partially reversed the effect of EVs on promoting COAD-induced angiogenesis. CAFs-EVs promoted tumor proliferation and angiogenesis of COAD <i>in vivo</i>. CAFs-EVs delivered miR-135b-5p into COAD cells to downregulate FOXO1 and promote HUVECs proliferation, migration, and angiogenesis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dai</LastName>
            <ForeName>Xiaoyu</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anus &amp; Intestine Sugery, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo City, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Yangyang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Pharmacy Department, Ningbo Eye Hospital, Ningbo City, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>Mingjun</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-1672-8031</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Anus &amp; Intestine Sugery, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo City, Zhejiang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cancer Biol Ther</MedlineTA>
        <NlmUniqueID>101137842</NlmUniqueID>
        <ISSNLinking>1538-4047</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C085126">FOXO1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000071161">Forkhead Box Protein O1</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C467200">Foxo1 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000230" MajorTopicYN="Y">Adenocarcinoma</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000072645" MajorTopicYN="Y">Cancer-Associated Fibroblasts</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071161" MajorTopicYN="N">Forkhead Box Protein O1</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061307" MajorTopicYN="N">Human Umbilical Vein Endothelial Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009389" MajorTopicYN="N">Neovascularization, Pathologic</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Cancer-associated fibroblasts</Keyword>
        <Keyword MajorTopicYN="Y">Colorectal adenocarcinoma</Keyword>
        <Keyword MajorTopicYN="Y">FOXO1</Keyword>
        <Keyword MajorTopicYN="Y">HUVECS</Keyword>
        <Keyword MajorTopicYN="Y">SW480/HCT116</Keyword>
        <Keyword MajorTopicYN="Y">angiogenesis</Keyword>
        <Keyword MajorTopicYN="Y">extracellular vesicles</Keyword>
        <Keyword MajorTopicYN="Y">miR-135b-5p</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>31</Day>
          <Hour>17</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35100092</ArticleId>
        <ArticleId IdType="pmc">PMC8812748</ArticleId>
        <ArticleId IdType="doi">10.1080/15384047.2021.2017222</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Karpisheh V, Nikkhoo A, Hojjat-Farsangi M, Namdar A, Azizi G, Ghalamfarsa G, Sabz G, Yousefi M, Yousefi B, Jadidi-Niaragh F, et al. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer. Prostaglandins Other Lipid Mediat. 2019;144:106338. DOI:10.1016/j.prostaglandins.2019.106338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.prostaglandins.2019.106338</ArticleId>
            <ArticleId IdType="pubmed">31100474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skh L, Martin A.. 
Mismatch repair and colon cancer: mechanisms and therapies explored. Trends Mol Med. 2016;22(4):274–289. DOI:10.1016/j.molmed.2016.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molmed.2016.02.003</ArticleId>
            <ArticleId IdType="pubmed">26970951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng M, Zhu L, Li L, Kang C. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1. Cell Mol Biol Lett. 2017;22:12. DOI:10.1186/s11658-017-0041-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s11658-017-0041-5</ArticleId>
            <ArticleId IdType="pmc">PMC5514464</ArticleId>
            <ArticleId IdType="pubmed">28725241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta R, Bhatt LK, Johnston TP, Prabhavalkar KS. Colon cancer stem cells: potential target for the treatment of colorectal cancer. Cancer Biol Ther. 2019;20(8):1068–1082. DOI:10.1080/15384047.2019.1599660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15384047.2019.1599660</ArticleId>
            <ArticleId IdType="pmc">PMC6606008</ArticleId>
            <ArticleId IdType="pubmed">31050577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai YP, Shang K, Chen H, Ding F, Wang Z, Liang C, Xu, Y, Sun , M, Y, Y. FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7. Cancer Sci. 2015;106:1278–1287. DOI:10.1111/cas.12745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cas.12745</ArticleId>
            <ArticleId IdType="pmc">PMC4637995</ArticleId>
            <ArticleId IdType="pubmed">26183471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unterleuthner D, Neuhold P, Schwarz K, Janker L, Neuditschko B, Nivarthi H, Crncec I, Kramer N, Unger C, Hengstschläger M, et al. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis. 2020;23(2):159–177. DOI:10.1007/s10456-019-09688-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10456-019-09688-8</ArticleId>
            <ArticleId IdType="pmc">PMC7160098</ArticleId>
            <ArticleId IdType="pubmed">31667643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ando N, Hara M, Shiga K, Yanagita T, Takasu K, Nakai N, Maeda, Y, Hirokawa, T, Takahashi, H, Ishiguro, H, et al. Eicosapentaenoic acid suppresses angiogenesis via reducing secretion of IL6 and VEGF from colon cancerassociated fibroblasts. Oncol Rep. 2019;42:339–349. DOI:10.3892/or.2019.7141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/or.2019.7141</ArticleId>
            <ArticleId IdType="pubmed">31059084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo L, Li B, Yang J, Shen J, Ji J, Miao M. Fibroblastderived exosomal microRNA369 potentiates migration and invasion of lung squamous cell carcinoma cells via NF1mediated MAPK signaling pathway. Int J Mol Med. 2020;46:595–608. DOI:10.3892/ijmm.2020.4614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ijmm.2020.4614</ArticleId>
            <ArticleId IdType="pmc">PMC7307814</ArticleId>
            <ArticleId IdType="pubmed">32467987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487–514. DOI:10.1146/annurev-biochem-013118-111902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-biochem-013118-111902</ArticleId>
            <ArticleId IdType="pubmed">31220978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang XY, Huang ZL, Huang J, Xu B, Huang XY, Xu YH, Zhou J, Tang Z-Y. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Cancer Res. 2020;39(1):20. DOI:10.1186/s13046-020-1529-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13046-020-1529-9</ArticleId>
            <ArticleId IdType="pmc">PMC6979009</ArticleId>
            <ArticleId IdType="pubmed">31973767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen S, Wang Y, Wang T, Hou Y. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018;8(14):3932–3948. DOI:10.7150/thno.25541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.25541</ArticleId>
            <ArticleId IdType="pmc">PMC6071523</ArticleId>
            <ArticleId IdType="pubmed">30083271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang F, Li L, Piontek K, Sakaguchi M, Selaru FM. Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma. Hepatology. 2018;67(3):940–954. DOI:10.1002/hep.29586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.29586</ArticleId>
            <ArticleId IdType="pmc">PMC5826829</ArticleId>
            <ArticleId IdType="pubmed">29023935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xi X, Teng M, Zhang L, Xia L, Chen J, Cui Z. Retracted: microRNA-204-3p represses colon cancer cells proliferation, migration, and invasion by targeting HMGA2. J Cell Physiol. 2020;235(2):1330–1338. DOI:10.1002/jcp.29050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.29050</ArticleId>
            <ArticleId IdType="pubmed">31286521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu L, Xu H, Zhao H, Sui D. MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor alpha expression. J Drug Target. 2021;29(3):300–309. DOI:10.1080/1061186X.2020.1833017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/1061186X.2020.1833017</ArticleId>
            <ArticleId IdType="pubmed">33032456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang K, Li D, Wang M, Xu Z, Chen X, Liu Q, Sun W, Li J, Gong Y, Liu D, et al. Exposure to blue light stimulates the proangiogenic capability of exosomes derived from human umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2019;10(1):358. DOI:10.1186/s13287-019-1472-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13287-019-1472-x</ArticleId>
            <ArticleId IdType="pmc">PMC6883639</ArticleId>
            <ArticleId IdType="pubmed">31779691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proenca MA, Biselli JM, Succi M, Severino FE, Berardinelli GN, Caetano A, Reis RM, Hughes DJ, Silva AE. Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis. World J Gastroenterol. 2018;24(47):5351–5365. DOI:10.3748/wjg.v24.i47.5351.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v24.i47.5351</ArticleId>
            <ArticleId IdType="pmc">PMC6305535</ArticleId>
            <ArticleId IdType="pubmed">30598580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren B. FoxO1 transcriptional activities in VEGF expression and beyond: a key regulator in functional angiogenesis?
J Pathol. 2018;245(3):255–257. DOI:10.1002/path.5088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.5088</ArticleId>
            <ArticleId IdType="pubmed">29691864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin Y, Li L, Wang F, Zhou X, Liu Y, Yin Y, Qi X. Knockdown of Mir-135b sensitizes colorectal cancer cells to oxaliplatin-induced apoptosis through increase of FOXO1. Cell Physiol Biochem. 2018;48(4):1628–1637. DOI:10.1159/000492284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000492284</ArticleId>
            <ArticleId IdType="pubmed">30071508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang B, Wang Y, Yan Z, Sun Y, Su C. Colorectal cancer cell-derived exosomes promote proliferation and decrease apoptosis by activating the ERK pathway. Int J Clin Exp Pathol. 2019;12(7):2485–2495.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6949542</ArticleId>
            <ArticleId IdType="pubmed">31934075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, et al. Colon cancer. Crit Rev Oncol Hematol. 2010;74(2):106–133. DOI:10.1016/j.critrevonc.2010.01.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.critrevonc.2010.01.010</ArticleId>
            <ArticleId IdType="pubmed">20138539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong ME, Chen Y, Xiao Y, Xu L, Zhang G, Lu J, Qiu H, Ge W, Wu B. Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location. EBioMedicine. 2019;50:211–223. DOI:10.1016/j.ebiom.2019.11.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2019.11.003</ArticleId>
            <ArticleId IdType="pmc">PMC6921233</ArticleId>
            <ArticleId IdType="pubmed">31753726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248–1264. DOI:10.1016/j.cell.2019.01.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2019.01.021</ArticleId>
            <ArticleId IdType="pmc">PMC6410740</ArticleId>
            <ArticleId IdType="pubmed">30849371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sullivan R, Maresh G, Zhang X, Salomon C, Hooper J, Margolin D, Li L. The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond. Front Endocrinol (Lausanne). 2017;8:194. DOI:10.3389/fendo.2017.00194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fendo.2017.00194</ArticleId>
            <ArticleId IdType="pmc">PMC5550719</ArticleId>
            <ArticleId IdType="pubmed">28848498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paul D, Roy A, Nandy A, Datta B, Borar P, Pal SK, Senapati, D, Rakshit, T. Identification of biomarker hyaluronan on colon cancer extracellular vesicles using correlative AFM and spectroscopy. J Phys Chem Lett. 2020;11(14):5569–5576. DOI:10.1021/acs.jpclett.0c01018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.jpclett.0c01018</ArticleId>
            <ArticleId IdType="pubmed">32573237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maciel E, Mansuy IM. Extracellular vesicles and their miRNA Cargo: a means of communication between soma and germline in the mammalian reproductive system. Chimia (Aarau). 2019;73(5):356–361. DOI:10.2533/chimia.2019.356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2533/chimia.2019.356</ArticleId>
            <ArticleId IdType="pubmed">31118116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, Paulus-Hock V, Hart J, Ueno L, Grivennikov S, Lovat F, et al. MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell. 2014;25(4):469–483. DOI:10.1016/j.ccr.2014.03.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2014.03.006</ArticleId>
            <ArticleId IdType="pmc">PMC3995091</ArticleId>
            <ArticleId IdType="pubmed">24735923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding B, Yao M, Fan W, Lou W. Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer. Aging (Albany NY). 2020;12(6):5259–5279. DOI:10.18632/aging.102945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/aging.102945</ArticleId>
            <ArticleId IdType="pmc">PMC7138558</ArticleId>
            <ArticleId IdType="pubmed">32221048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chae YC, Kim JY, Park JW, Kim KB, Oh H, Lee KH, Seo, SB. FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer. Nucleic Acids Res. 2019;47(4):1692–1705. DOI:10.1093/nar/gky1230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gky1230</ArticleId>
            <ArticleId IdType="pmc">PMC6393239</ArticleId>
            <ArticleId IdType="pubmed">30535125</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
